OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism
Carolin Siech, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 363-363
Open Access | Times Cited: 22

Showing 22 citing articles:

Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
Guoqiang Liu, Minggang Zhu, Mingrui Zhang, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1287-1287
Open Access | Times Cited: 22

Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
T. Pejcic, Zoran Todorović, Siniša Đurašević, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2939-2939
Open Access | Times Cited: 14

Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based study
Yan Hiu Athena Lee, Jeremy Man Ho Hui, Jeffrey Shi Kai Chan, et al.
The Prostate (2022) Vol. 83, Iss. 1, pp. 119-127
Open Access | Times Cited: 19

Gestational colorectal cancer: Mechanisms, treatments, and prognosis
Xingnan Ge, Yanru Feng, Shisheng Tan, et al.
International Journal of Cancer (2025)
Closed Access

Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer
Renjith P. Johnson, Chandrahas Koumar Ratnacaram, Lalit Kumar, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100865-100865
Closed Access | Times Cited: 13

Integrins and Actions of Androgen in Breast Cancer
Chung‐Che Tsai, Yu‐Chen S. H. Yang, Yi‐Fong Chen, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2126-2126
Open Access | Times Cited: 8

Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells
Mazen A. Juratli, He Zhou, Elsie Oppermann, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2430-2430
Open Access | Times Cited: 10

Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review
Samantha Acevedo, María Fernanda Segovia, Erwin de la Fuente-Ortega
Nutrients (2024) Vol. 16, Iss. 13, pp. 2026-2026
Open Access | Times Cited: 1

Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro
Hui Xie, Jochen Rutz, Sebastian Maxeiner, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 623-623
Open Access | Times Cited: 1

Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities
Noha Mousaad Elemam, Hassan Hotait, Mohamed A. Saleh, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1

The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells
Ivana Samaržija, Vasyl Lukiyanchuk, Marija Lončarić, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

Green synthesis of gold and silver nanoparticles as antidiabetic and anticancerous agents
Muhammad Asam Raza, Umme Farwa, Muhammad Waseem Mumtaz, et al.
Green Chemistry Letters and Reviews (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 3

4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells
Gabriela da Silva Guimarães, Antonielle Oliveira Cordeiro, Matheus Coutinho Gazolla, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 943-955
Closed Access | Times Cited: 2

The Impact of Nutrient Supply on Prostate Cancer Risk Worldwide
Jinjiang Jiang, Jie Yang, Bo Chen, et al.
Nutrients (2023) Vol. 15, Iss. 24, pp. 5131-5131
Open Access | Times Cited: 2

How is the AKT/mTOR pathway involved in cell migration and invasion?
JINGYAO XU, SHUANGLI HAO, KAIYUE HAN, et al.
Biocell (2023) Vol. 47, Iss. 4, pp. 773-788
Open Access | Times Cited: 1

Research Progress on the Association and Mechanism between Obesity and Prostate Cancer
热 娜古丽·艾海提
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 1941-1946
Closed Access

CYR61 promotes metastasis of prostate cancer cells through the p-AKT and AR signaling pathways
Greisha L. Ortiz-Hernández, Carmina S. Patrick, Stefan Hinz, et al.
Research Square (Research Square) (2024)
Closed Access

Evaluate the Serum of Irisin, Omentin-1, and Oxidative Status in Males with Prostatic Cancer
Maya Sultan, Talaat Abdallah, Mustafa Abdullah, et al.
Reports of Biochemistry and Molecular Biology (2024) Vol. 13, Iss. 1, pp. 23-30
Open Access

Page 1

Scroll to top